STOCK TITAN

[Form 4] Myomo Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Myomo, Inc. director Thomas F. Kirk reported open-market purchases of 50,000 shares of Myomo common stock on 08/18/2025 at an execution price of $1.10 per share (two transactions at $1.10 each). Following these purchases, Mr. Kirk beneficially owned 424,420 shares, held directly. The Form 4 was signed by an attorney-in-fact on 08/19/2025. The filing states the purchases were open-market trades and that details can be provided to the SEC upon request.

Thomas F. Kirk, amministratore di Myomo, Inc. ha dichiarato di aver acquistato sul mercato aperto 50.000 azioni di azioni ordinarie Myomo il 18/08/2025 a un prezzo di esecuzione di $1,10 per azione (due operazioni a $1,10 ciascuna). Dopo questi acquisti, il Sig. Kirk possedeva beneficiariamente 424.420 azioni, detenute direttamente. Il modulo Form 4 è stato firmato da un procuratore il 19/08/2025. La comunicazione specifica che gli acquisti sono stati effettuati sul mercato aperto e che i dettagli possono essere forniti alla SEC su richiesta.

Thomas F. Kirk, director de Myomo, Inc., informó compras en el mercado abierto de 50.000 acciones de acciones ordinarias de Myomo el 18/08/2025 a un precio de ejecución de $1,10 por acción (dos transacciones a $1,10 cada una). Tras estas compras, el Sr. Kirk poseía beneficiosamente 424.420 acciones, mantenidas de forma directa. El Formulario 4 fue firmado por un apoderado el 19/08/2025. La presentación indica que las compras fueron operaciones en el mercado abierto y que los detalles pueden facilitarse a la SEC si se solicitan.

Myomo, Inc. 이사 Thomas F. Kirk2025-08-18에 Myomo 보통주 50,000주를 공개시장 매수로 주당 $1.10에(각각 $1.10로 두 건) 취득했다고 보고했습니다. 이번 매수 후 Kirk 씨는 직접 보유 형태로 424,420주를 실질적으로 소유하게 되었습니다. Form 4는 2025-08-19에 대리인에 의해 서명되었습니다. 제출서에는 해당 매수들이 공개시장 거래였으며 요청 시 SEC에 관련 세부 정보를 제공할 수 있다고 명시되어 있습니다.

Thomas F. Kirk, administrateur de Myomo, Inc., a déclaré des achats en marché ouvert de 50 000 actions d'actions ordinaires Myomo le 18/08/2025 au prix d'exécution de 1,10 $ par action (deux transactions à 1,10 $ chacune). À la suite de ces achats, M. Kirk détenait bénéficiairement 424 420 actions, détenues directement. Le formulaire 4 a été signé par un mandataire le 19/08/2025. Le dépôt indique que les achats ont été effectués en marché ouvert et que des détails peuvent être fournis à la SEC sur demande.

Thomas F. Kirk, Direktor von Myomo, Inc., meldete Offenmarktkäufe von 50.000 Aktien der Stammaktien von Myomo am 18.08.2025 zu einem Ausführungspreis von $1,10 pro Aktie (zwei Transaktionen zu je $1,10). Nach diesen Käufen besaß Herr Kirk wirtschaftlich 424.420 Aktien, die direkt gehalten werden. Das Formular 4 wurde am 19.08.2025 von einem Bevollmächtigten unterzeichnet. Die Meldung gibt an, dass es sich um Offenmarktgeschäfte handelte und dass Details der SEC auf Anfrage zur Verfügung gestellt werden können.

Positive
  • Director purchase disclosed: The Form 4 reports an open-market acquisition of 50,000 shares, indicating insider activity is transparently reported.
  • Clear post-transaction ownership: Reporting person beneficially owns 424,420 shares following the reported transactions.
  • Complete transaction details provided: Transaction date, price ($1.10), and transaction code (P) are included, and the filing is signed by an authorized attorney-in-fact.
Negative
  • None.

Insights

TL;DR: Director executed a notable open-market buy of 50,000 shares at $1.10, increasing direct ownership to 424,420 shares.

The transaction is a simple, disclosed open-market purchase reported on Form 4. The purchase price and share count are explicit, and the filing confirms direct beneficial ownership after the trades. From a trading-disclosure perspective, the report is complete for non-derivative activity and includes the reporting attorney-in-fact signature. There are no earnings or capital-structure changes disclosed in this filing.

TL;DR: A company director reported purchased stock, properly disclosed on Form 4 with required signature.

The filing shows compliance with Section 16 reporting: the reporting person is identified as a director, transaction codes and share counts are provided, and the form is executed by an attorney-in-fact. The filer notes the trades were open-market and offers to provide transaction details to the SEC on request, which is standard. No derivatives, plans, or exemptions are indicated in the disclosure.

Thomas F. Kirk, amministratore di Myomo, Inc. ha dichiarato di aver acquistato sul mercato aperto 50.000 azioni di azioni ordinarie Myomo il 18/08/2025 a un prezzo di esecuzione di $1,10 per azione (due operazioni a $1,10 ciascuna). Dopo questi acquisti, il Sig. Kirk possedeva beneficiariamente 424.420 azioni, detenute direttamente. Il modulo Form 4 è stato firmato da un procuratore il 19/08/2025. La comunicazione specifica che gli acquisti sono stati effettuati sul mercato aperto e che i dettagli possono essere forniti alla SEC su richiesta.

Thomas F. Kirk, director de Myomo, Inc., informó compras en el mercado abierto de 50.000 acciones de acciones ordinarias de Myomo el 18/08/2025 a un precio de ejecución de $1,10 por acción (dos transacciones a $1,10 cada una). Tras estas compras, el Sr. Kirk poseía beneficiosamente 424.420 acciones, mantenidas de forma directa. El Formulario 4 fue firmado por un apoderado el 19/08/2025. La presentación indica que las compras fueron operaciones en el mercado abierto y que los detalles pueden facilitarse a la SEC si se solicitan.

Myomo, Inc. 이사 Thomas F. Kirk2025-08-18에 Myomo 보통주 50,000주를 공개시장 매수로 주당 $1.10에(각각 $1.10로 두 건) 취득했다고 보고했습니다. 이번 매수 후 Kirk 씨는 직접 보유 형태로 424,420주를 실질적으로 소유하게 되었습니다. Form 4는 2025-08-19에 대리인에 의해 서명되었습니다. 제출서에는 해당 매수들이 공개시장 거래였으며 요청 시 SEC에 관련 세부 정보를 제공할 수 있다고 명시되어 있습니다.

Thomas F. Kirk, administrateur de Myomo, Inc., a déclaré des achats en marché ouvert de 50 000 actions d'actions ordinaires Myomo le 18/08/2025 au prix d'exécution de 1,10 $ par action (deux transactions à 1,10 $ chacune). À la suite de ces achats, M. Kirk détenait bénéficiairement 424 420 actions, détenues directement. Le formulaire 4 a été signé par un mandataire le 19/08/2025. Le dépôt indique que les achats ont été effectués en marché ouvert et que des détails peuvent être fournis à la SEC sur demande.

Thomas F. Kirk, Direktor von Myomo, Inc., meldete Offenmarktkäufe von 50.000 Aktien der Stammaktien von Myomo am 18.08.2025 zu einem Ausführungspreis von $1,10 pro Aktie (zwei Transaktionen zu je $1,10). Nach diesen Käufen besaß Herr Kirk wirtschaftlich 424.420 Aktien, die direkt gehalten werden. Das Formular 4 wurde am 19.08.2025 von einem Bevollmächtigten unterzeichnet. Die Meldung gibt an, dass es sich um Offenmarktgeschäfte handelte und dass Details der SEC auf Anfrage zur Verfügung gestellt werden können.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KIRK THOMAS F

(Last) (First) (Middle)
C/O MYOMO, INC.
45 BLUE SKY DR., SUITE 101

(Street)
BURLINGTON MA 01803

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MYOMO, INC. [ MYO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/18/2025 P 50,000(1) A $1.1(2) 424,420 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents open market purchases.
2. Shares were purchased in two transactions, each executing at $1.10 per share. Reporting Party agrees to provide details of the transactions to the SEC upon request.
/s/ David A. Henry, Attorney-in-Fact 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What shares did Myomo director Thomas F. Kirk buy as reported on Form 4?

He purchased 50,000 shares of Myomo common stock in open-market transactions on 08/18/2025.

At what price were the Myomo (MYO) shares purchased on 08/18/2025?

The shares were purchased at $1.10 per share, executed as two transactions at that price.

How many Myomo shares does Thomas F. Kirk beneficially own after the reported purchase?

Following the reported transactions, he beneficially owned 424,420 shares (direct ownership).

Who signed the Form 4 reporting Thomas F. Kirk's transactions?

The Form 4 is signed by David A. Henry, Attorney-in-Fact, dated 08/19/2025.

Was the purchase part of a Rule 10b5-1 plan or an open-market trade?

The filing states the transactions represent open-market purchases; no Rule 10b5-1 plan is indicated.
Myomo

NYSE:MYO

MYO Rankings

MYO Latest News

MYO Latest SEC Filings

MYO Stock Data

42.34M
32.46M
6.62%
66.28%
4.11%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
BOSTON